renal transplant Flashcards

(98 cards)

1
Q

what is criteria for DCD

A

absence of circulation, not EKG silence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

causes of graft failure after first yr - 5

A

chronic allograft nephropathy (scarring) 40%, death 30% (CVD), acute rejection 7%, noncompliance 3%, recurrence 2%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

top 3 causes of ESRD leading to txp

A

glomerular disease (30%), DM (20%), HTN (20%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

major factors affecting long term outcome - 5

A

HLA match, rejection (acute/ chronic), prior failed txp, comorbidities, race

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

relative contraindications to txp - 6

A

active infection, malignancy (document cure), active ongoing renal disease (SLE), hyperoxaluria type 1, severe atherosclerosis with uncorrectable disease, social problems (non compliance, psych, morbid obesity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

problem with FSGS and transplant

A

25% recur leading to upto 65% graft failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is extended criteria

A

> 60 yo, OR > 50 yo with 2(cr > 1.5, HTN, CVA death)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

where are HLA found

A

surface of NUCLEATED cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what chromosome is HLA on

A

6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

parts to class 1 HLA antigen

A

3 alpha and 1 b2microglobulin with 1 carboxy terminal through cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

parts to class 2 HLA antigen

A

2 alpha, 2 beta, 2 carboxy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does rejection happen

A

HLA molecules on surface shed into circulation, APC’s (host or donor) in LN’s present molecule to T cells, stimulates cytokine release, which then go to graft to damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is signal 1

A

APC’s (host or donor) in LN’s present MHC to T cells - difference in binding cleft between alpha subunits sends signal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the result of signal 1

A

STARTS cytokine production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is signal 2

A

AKA costimulation. sets of receptors on APC bind to t-cell –> stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is signal 3

A

cytokine IL2 released by CD4 is most potent. Stimulates CD8 t cells to become cytotoxic and attack organ with HLA organ it was sensitized to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

CD4 vs CD8 t cells

A

CD4 (helper) activate CD8 (killer) and b-cells, CD8 = cytotoxic via perforins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

class 1 vs 2 HLA and CD4 vs 8 T cell

A

class 1 has binding site for CD8, class 2 for CD4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what types of cells mediate acute rejection

A

donor APC’s present MHC to recipient T cells immediately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what types of cells mediate chronic rejection

A

recipient APC re-packages MHC to recipient t-cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is costimulation

A

signal 1 and 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

significance of co-stimulation

A

nieve t-cells become anergic/ undergo apoptosis without signal 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

hyperacute timing

A

min - hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

acute timing

A

d- yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
chronic timing?
mo - yrs
26
hyperacute mediating factors
preformed ab's (humoral)
27
acute mediating factors - 2
cellular/ humoral (ab's) responses
28
chronic mediating factor - 3
cellular/humoral response/ viral
29
hyperacute rejection primary finding
intravascular coagulation/ hemorrhagic necrosis
30
acute rejection primary finding
tissue destruction
31
chronic rejection primary finding
obliterative fibrosis
32
vessel endothelium @ hyperacute rejection
ab's attack walls of endothelium and disrupt vessel
33
prevention of hyperacute rejection
crossmatch to ID if recipient has circulating preformed ab's to HLA molecules on donor
34
first step in diagnosing acute rejection
biopsy
35
acute rejection histology - 2
infiltrate of mononuclear cells and plasma cells in interstitum
36
effect of acute rejection on kidney
causes tubulitis --> overrides tubules
37
first line therapy of acute rejection
high dose steroids
38
second line therapy given when? For acute rejection
vascular rejection aka Banf grade 2 or 3
39
how can you identify antibody mediated acute rejection
antibodies on artery walls on biopsy.
40
what are second line therapies for acute rejection - 3
anti-t cell ab's (OKT3), plasmapheresis (remove AB's), IVIG (block ab's)
41
how to treat antibody mediated acute rejection
second line therapies (OKT3, plasmapheresis, IVIG)
42
gross findings in chronic rejection
atrophy/ fibrosis - cortical atrophy, whiteish kidney (fibrosis)
43
histologic findings in chronic rejection - 4
1. interstitial fibrosis / tubular atrophy, 2. vascular intimal hyperplasia, 3. arteriolar hyalinosis, 4. glomerulopathy (double countour GBM)
44
intimal arteritis of chronic allograft nephropathy histo findings
lumen occluded - intima inflamed and infiltrated by inflammatory cells - occluding lumen
45
2 types of chronic allograft nephropathy
antigen dependent and independent
46
what is antigen dependent CAN - 3
after episodes of acute rejection, re-transplantation (preformed ab's), triggering HLA system
47
antigen independent CAN - 5
ischemia/reperfusion at txp, nephrotoxic drugs, viral, hyperlipidemia, HTN
48
how does combination antirejection therapy work
use combination drugs that work at different points in cell cycle -synergistic effect and can use lower doses overall to minimize toxicity
49
common maintenance cocktail
calceneurin inhibitor, antiproliferative agent, steroid --> tacrolimus, mycophenolic acid, prednisone
50
cyclosporine and tacrolimus - what class r they
calcineurin inhibitors
51
most common side effect of calceneurin inhib - 2
nephrotoxic and bone marrow toxic
52
role of calineurin in CD4 T cell activation
CD4 - MHC engagement + 2nd signal + CD3 = increased intracellular calcium --> calcineurin activation --> dephosphorylation of NFAT and transfer to nucleus --> t cell activation and IL2 production
53
calcineurin inhib MOA
blocks IL2 gene transcription, preventing T cell activaiton early on
54
calcineurin inhib side effects - 5
nephrotoxic, HTN, DM, cosmetic changes (hersutism, gingival hyperplasia), neurotoxic
55
what is C2 level
cyclosporin Area under the curve level 2 hrs after po dose
56
how to monitor tacrolimus level
trough
57
sirolimus class
mtor inhibitor
58
mtor side effects - 3
marrow toxic, hyperlipidemia, slow wound healing
59
OKT3 MOA
monoclonal ab blocking CD3 and t cell activation
60
thymoglobulin MOA
AB's against multiple cell surface antigens = profound T cell activation for weeks
61
mycophenolate mofetil, azathioprine - what class?
antiproliferative or antimetabolites agents
62
antiproliferative agent common side effect
bone marrow supression
63
mycofenolate side effect - 1
GI toxicity, diarrhea
64
azathioprine side effect - 1
liver toxicity
65
what is carrel patch
take a piece of aorta and place onto iliac when multiple vessels
66
pediatric pt receiving adult kidney - where?
anastamosed to aorta/ivc
67
pediatric en bloc to adult - vascular anastamosis
pediatric aorta and ivc attached to iliac
68
initial workup of txp dysfunction (non-immune causes) - 4
eval volume status, r/o bladder ourlet obstruction, screen for infection (blood/urine), check calcineurin levels
69
def of transplant dysfxn
cr > 20% baseline
70
effect of large pelvic lymphocele
can compress illiacs --> leg edema, decreased flow to kidney, DVT
71
most common viral post txp infection
CMV in 10-20%
72
cmv prophylaxis
gancyclovir
73
CMV features- 5
happens at 42 days postop, affected organs: GIT, liver, glomerulopathy, retinitis
74
BK virus sx - 5
rising cr (BK nephropathy), hemorrhagic cystitis, ureteral stenosis, sterile pyuria (viuria)
75
BK virus mgmt
reduce immunosupression, stop mycophenolate, start lefunomide (pyrimidine synthesis inhibitor) and cidofovir
76
most common fungal infections - 2
candida and torulopsis
77
fungal prophylaxis
fluconazole
78
opportunistic infection and prophylaxis
pcp & bactrim
79
live donor exclusion - age - 2
< 18 (consent) or > 70 - anesthetic risk and poor kidney
80
live donor exclusion - BP
> 140/90 in blacks, 1 drug HTN in whites w/ no LVH in whites considered
81
live donor exclusion - kidney - 4
proteinuria > 200 F 250 M, GFR< 80, ADPKD, kidney stones (multiple or clinically active)
82
live donor exclusion - others - 5
DM, prior cancer, hypercoagulable, psychosocial stressor, very abnormal CT
83
which kidney to remove in donor -4
single renal artery, left kidney (longer vein), smaller kidney, the one with abnormalities
84
general principal of donor nx
leave donor with better kidney
85
renal recovery in donor
under 50 yo have hypertrophy to final 65-75% total renal function
86
what is a pretransplant gu eval for recipient? - 4
sterile urine, VCUG if suspected abnormality, BPH - resect if not anuric
87
living vs cadaveric donor and success
poorly matched living is better than matched cadaveric
88
crossmatch: positive T cell/ class 1
no txp
89
who gets first transplant only - 3
pos T cell flow crossmatch only, negative T cell positive B cell, positive B cell flow
90
perioperative maneuvers that reduce impact of ischemia reperfusion - 5
hydration, mannitol, lasix, intra-arterial verapamil, low dose dopamine
91
which branching vessels can be tied off
small upper pole, not lower pole as may supply ureter
92
vascular thrombosis/leak mgmt
reoperate
93
urine leak/ureteral obstruction mgmt
endoscopic mgmt, or reoperation if endoscopy fails or necrosis
94
lymphocele presentation - 2
ureteral obstruction (rising cr), or iliac vein compression (leg edema/DVT)
95
lymphocele mgmt - 3
large and symptomatic require tx: percutaneous drainage, sclerosis, peritoneal window
96
ipp post TXP
considered safe
97
ureteral stents and transplant
higher risk of infection unless abx added
98
drug used to prevent and treat acute rejection
thymoglobulin